This report describes retinitis pigmentosa 13 (RP13), which is a subtype of retinitis pigmentosa; RP13 exhibits autosomal dominant inheritance. The gene implicated in this disease is PRPF8, a highly conserved component of spliceosomes. There is a single orthologous gene in Drosophila, Prp8, for which loss-of-function mutations, RNAi-targeting constructs, and alleles caused by insertional mutagenesis have been generated.
The human PRPF8 gene has not been introduced into flies.
RP13 is one of several autosomal dominant subtypes of retinitis pigmentosa associated with genes involved in pre-mRNA splicing. A second example studied in flies is retinitis pigmentosa 11 (FBhh0000200). One of the interesting questions is how genetic perturbations affecting core splicing factors manifest in tissue-specific pathogenesis rather than a systemic disease.
Missense mutations analogous to disease-implicated variants in the human gene have been created in Dmel\Prp8 and introduced into UAS constructs. Variant(s) implicated in human disease tested (as analogous mutation in fly gene): S2178F in the fly Prp8 gene (corresponds to S2118F in the human PRPF8 gene); P2361P in the fly Prp8 gene (corresponds to P2301T in the human PRPF8 gene); F2374L in the fly Prp8 gene (corresponds to F2314L in the human PRPF8 gene); H2369P in the fly Prp8 gene (corresponds to H2309P in the human PRPF8 gene); H2369R in the fly Prp8 gene (corresponds to H2309R in the human PRPF8 gene); R2370G in the fly Prp8 gene (corresponds to R2310G in the human PRPF8 gene); R2370K in the fly Prp8 gene (corresponds to R2310K in the human PRPF8 gene); R2370S in the fly Prp8 gene (corresponds to R2310S in the human PRPF8 gene); Y2395N in the fly Prp8 gene (corresponds to Y2334N in the human PRPF8 gene). All nine tested mutations are within the C-terminal Jab1/MPN domain.
Using different GAL4 drivers, phenotypic effects in several different tissues and stages have been assessed for each of the analogous variants. The pathogenicity of the analogous Prp8 Drosophila mutations correlates with the severity of clinical phenotypes in patients carrying the equivalent mutations. In the developing eye primordium, uncommitted epithelial precursors rather than differentiated photoreceptors appear sensitive to Prp8 malfunction; the affected tissue mounts stress and cytoprotective responses. Results in flies support the hypothesis that pathogenicity may result from dominant-negative or gain-of-function mechanisms, rather than from haploinsufficiency.
[updated Aug. 2020 by FlyBase; FBrf0222196]
Retinitis pigmentosa (RP) refers to a heterogeneous group of inherited ocular diseases that result in a progressive retinal degeneration affecting 1 in 3,000 to 5,000 people (Veltel et al., 2008; pubmed:18376416). Symptoms include night blindness, the development of tunnel vision, and slowly progressive decreased central vision starting at approximately 20 years of age. [from MIM:268000; 2016.03.07]
The rate and extent of disease progression vary markedly among RP patients, in some cases, even within the same family. [from MIM:600059; 2020.08.04]
[RETINITIS PIGMENTOSA 13; RP13](https://omim.org/entry/600059)
[PRE-mRNA-PROCESSING FACTOR 8; PRPF8](https://omim.org/entry/607300)
Retinitis pigmentosa-13 (RP13) is caused by heterozygous mutation in the PRPF8 gene. [from MIM:600059; 2020.08.04]
The protein encoded by PRPF8 is a component of both U2- and U12-dependent spliceosomes, and is essential for the catalytic step II in pre-mRNA splicing process. It functions as a scaffold that mediates the ordered assembly of spliceosomal proteins and snRNAs; contains several WD repeats, which function in protein-protein interactions. [from Gene Cards, PRPF8; 2020.08.04]
One to one:1 human gene to 1 Drosophila gene.
High-scoring ortholog of human PRPF8 (1 Drosophila to 1 human). Dmel\Prp8 shares 92% identity and 96% similarity with the human gene.